Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients

Major depression disorder (MDD) is the most widespread mental disorder. Selective serotonin reuptake inhibitors (SSRIs) are used as first-line MDD treatment but are effective in <70% of patients. Thus, biomarkers for the early identification of treatment-resistant (TR) MDD patients are needed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Rzezniczek, S, Obuchowicz, M, Datka, W, Siwek, M, Dudek, D, Kmiotek, K, Oved, K, Shomron, N, Gurwitz, D, Pilc, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545648/
https://www.ncbi.nlm.nih.gov/pubmed/27244236
http://dx.doi.org/10.1038/tp.2016.90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545648/
https://www.ncbi.nlm.nih.gov/pubmed/27244236
http://dx.doi.org/10.1038/tp.2016.90

Ejemplares similares